...
首页> 外文期刊>Scientific reports. >Propensity score-matching analysis comparing laparoscopic and open pancreaticoduodenectomy in elderly patients
【24h】

Propensity score-matching analysis comparing laparoscopic and open pancreaticoduodenectomy in elderly patients

机译:腹腔镜和开放胰腺癌切除术治疗老年患者的倾向分数分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

There is little evidence on the safety and benefits of laparoscopic pancreaticoduodenectomy (LPD) in elderly patients; therefore, we evaluated the feasibility and efficacy of this procedure by comparing perioperative and oncological outcomes between LPD and open pancreaticoduodenectomy (OPD) in elderly patients. We retrospectively reviewed the data of 1,693 patients who underwent PD to manage periampullary tumours at a single institution between January 2014 and June 2017. Of these patients, 326 were elderly patients aged ≥70 years, with 56 patients allocated to the LPD group and 270 to the OPD group. One-to-one propensity score matching (56:56) was used to match the baseline characteristics of patients who underwent LPD and OPD. LPD was associated with significantly fewer clinically significant postoperative pancreatic fistulas (7.1% vs. 21.4%), fewer analgesic injections (10 vs. 15.6 times; p?=?0.022), and longer operative time (321.8 vs. 268.5?minutes; p?=?0.001) than OPD in elderly patients. There were no significant differences in 3-year overall and disease-free survival rates between the LPD and OPD groups. LPD had acceptable perioperative and oncological outcomes compared with OPD in elderly patients. LPD is a reliable treatment option for elderly patients with periampullary tumours.
机译:关于腹腔镜胰腺增生症(LPD)在老年患者中的安全性和益处几乎没有证据;因此,我们通过在老年患者中比较LPD和开放胰岛素二霉菌切除术(OPD)之间的围手术期和肿瘤学结果来评估该程序的可行性和功效。我们回顾性地审查了1,693名患者的数据,接受了PD,在2014年1月至2017年1月至2017年1月至2017年6月之间管理伪装肿瘤。这些患者,326名是老年患者≥70岁,56名患者分配给LPD集团和270名患者。 OPD组。一对一倾向得分(56:56)用于匹配接受LPD和OPD的患者的基线特征。 LPD与临床显着的术后胰腺瘘(7.1%与21.4%)有关,镇痛注射率较少(10 vs.15.6次; p?= 0.022),并且持续时间更长(321.8与268.5?分钟; p ?= 0.001)比老年患者的OPD。 LPD和OPD组之间的3年整体和无病生存率没​​有显着差异。与老年患者的OPD相比,LPD具有可接受的围手术期和肿瘤的结果。 LPD是针对老年血浆肿瘤患者的可靠治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号